Literature DB >> 1600037

Review article: non-steroidal, anti-inflammatory drugs--the extending scope of gastrointestinal side effects.

L Aabakken1.   

Abstract

The gastrointestinal side effects of non-steroidal, anti-inflammatory drugs extend beyond the duodenal bulb, and comprise a variety of lesions in all parts of the gut. Gastroduodenal ulceration is quantitatively dominant, although a major part of these lesions probably go unnoticed and heal spontaneously. Adaptation has been demonstrated for acetylsalicylic acid, and may be of importance for other substances as well. Non-steroidal anti-inflammatory drugs (NSAIDs) may induce relapse of inflammatory bowel disease. Permeability changes and mucosal inflammation are found in the small and large bowel in the majority of subjects taking NSAIDs, although the clinical significance is still not clear. Ulceration and perforation do, however, occur in this part of the gut as well. Treatment of NSAID-associated ulceration is similar to traditional ulcer treatment, possibly with extended treatment duration if the NSAID is continued. Prophylaxis is of some value, but is not required for every patient receiving an NSAID.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600037     DOI: 10.1111/j.1365-2036.1992.tb00258.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

Review 1.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

2.  Short term effects of indomethacin on rat small intestinal permeability. Role of eicosanoids and platelet activating factor.

Authors:  F Mion; J C Cuber; Y Minaire; J A Chayvialle
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

3.  Clinical, endoscopic and pathologic spectrum of non-steroidal anti-inflammatory drug-induced colitis.

Authors:  Bita Geramizadeh; Alireza Taghavi; Babak Banan
Journal:  Indian J Gastroenterol       Date:  2009-11-24

4.  A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2).

Authors:  R Huff; P Collins; S Kramer; K Seibert; C Koboldt; S Gregory; P Isakson
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.